The Subcommittee on Health hearing, titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices,” is set to take place on Wednesday, May 22, 2024, at 10:30 AM ET at 2322 Rayburn House Office Building. The hearing will focus on discussing the FDA’s regulation of drugs, biologics, and devices.
The Chairs of the House Energy and Commerce Committee Cathy McMorris Rodgers (R-WA) and Brett Guthrie (R-KY) announced the hearing. They emphasized the importance of engaging regularly with FDA officials to understand what is working well and what challenges persist. The Chairs stated that America is a leader in developing cutting-edge biomedical innovation, with countries around the globe looking to the FDA for guidance on safe and effective treatments and medical devices. Rebuilding public trust in government health agencies like the FDA requires greater transparency.
Witnesses at the hearing include Dr. Patrizia Cavazzoni, Director of the Center for Drug Evaluation and Research (CDER), Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), and Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH). The hearing will be open to the public and press, live streaming online at https://energycommerce.house.gov/.
For questions about the hearing or media inquiries please contact Emma Schultheis with Committee staff at Emma.Schultheis@mail.house.gov or Christopher Krepich at Christopher
